TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and Eric Hughes ...

The 'Reef Adapt' ... Researchers Use the Sounds of Healthy Coral Reefs to Encourage Growth of a New Species of Coral Larvae Oct. 23, 2024 — Healthy coral reefs echo with a chorus of grunts and ...

In its second pipeline-boosting deal in two days, Sanofi has pledged €469 million (around $490 million) upfront for rights to an anti-TL1A therapy being developed by Teva for inflammatory bowel ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

1 Day TEVA 0.23% DJIA 0.97% S&P 500 0.35% Health Care/Life Sciences 0.14% ...

After hours: November 22 at 7:58 p.m. EST ...